193 results on '"Badowski, Melissa E"'
Search Results
2. Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists
3. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
4. Assessing Immunity to Hepatitis A and Hepatitis B Among Individuals in Custody Living With HIV.
5. Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States
6. 1532. Guideline Adherence to Hepatitis B Virus (HBV) Screening and Vaccination in Patients Prescribed Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis (PrEP)
7. 1518. Prevalence of Integrase Inhibitor Resistance within an Urban Clinic Network After Adoption as First-line Therapy
8. Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV
9. Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
10. Weighing in on the Role of Integrase Strand Transfer Inhibitors (INSTIs) on Weight Gain: Fact or Fiction?
11. Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?
12. Personalizing Prevention: Advances in Pharmacotherapy for HIV Prevention
13. How to design and implement an outpatient antimicrobial stewardship programme
14. Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
15. Simplifying ARV Therapy in the Setting of Resistance
16. 2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy
17. 1103. Virologic and Immunologic Outcomes in People Living with HIV in a Correctional Setting During the SARS-CoV-2 Pandemic
18. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
19. Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
20. Providing Comprehensive Medication Management in Telehealth
21. Infections in Immunocompromised Patients: Faculty Materials
22. Infections in Immunocompromised Patients: Case-Based Learning
23. New Antiretroviral Treatment for HIV
24. Evaluation of Immunologic and Virologic Function in Reincarcerated Patients Living With HIV or AIDS
25. HIV: how to manage low-level viraemia in people living with HIV
26. Correctional healthcare: An opportunity for clinical pharmacists to lead and innovate.
27. Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens
28. 879. Evaluation of the Incidence of Hypertension, Diabetes, and Hyperlipidemia in Patients on Antiretroviral Therapy
29. Telemedicine for HIV Care: Current Status and Future Prospects
30. “Tele”‐ing the story of clinical pharmacy: Providing comprehensive medication management in a virtual environment
31. Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
32. Telehealth and technological applications in patient‐centered care: Implications for pharmacy learners and clinical pharmacists
33. Evaluation of viral suppression in re-incarcerated HIV prisoners followed in a telemedicine clinic.: 368.
34. Analysis of baseline HIV-1 genotypes in naïve subjects with HIV in a correctional setting.: 262E.
35. HIV telemedicine in the correctional setting.: 264.
36. Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
37. Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States
38. The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
39. The Rise of Telemedicine: Lessons from a Global Pandemic
40. Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
41. Doctor of Pharmacy studentsʼ perception of telemedicine prior to and following completion of a telemedicine course.: 45.
42. Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
43. 939. Immunity to Hepatitis A and/or Hepatitis B Viruses Among Inmates Living with HIV
44. 1044. The Incidence and Severity of Drug interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
45. 941. Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
46. 53. Attitudes and perceptions of postgraduate residents and fellows in telemedicine services at the University of Illinois at Chicago College of Pharmacy.
47. Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus
48. Can vitamins and/or supplements provide hope against coronavirus?
49. Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19
50. Role delineation for pharmacotherapy specialists: Re‐evaluating the clinical relevance of a patient‐centered credential
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.